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Introduction
Silylation, i.e., the substitution of hydrogen atoms of carboxylic, 
alcoholic, amino, etc. groups with tri-alkylsilyl groups (-SiR3), is a very 
powerful and convenient single step derivatization strategy which, in 
abstract, could convert a variety of polar compounds to trialkylsilyl 
derivatives which are eminently suitable for GCGasChromatography/
MSMassSpectrometry analysis [1,2]. 
The most popular silylation reagents are trimethylsilyl (TMS) 
donors (e.g., BSA↳[N,O-bis(trimethylsilyl)acetamide]; BSTFA↳[N,O-
bis(trimethylsilyl)trifluoroacetamide]; MSTFA↳[N-Methyl-N-(trimethylsilyl)
trifluoroacetamide]) eventually enriched with trimethylchlorosilane (TMCS) 
[2-4]:
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Typically, silylation procedures consist of a preliminary step in 
which the sample to be analyzed is carefully dried since water (and 
protic solvents) destroys silylation reagents. The anhydrous residue is 
then treated with a small volume of a mixture of silylation reagent and 
an aprotic solvent in a small vial which, finally, is hermetically sealed 
and forced through a heat treatment (which is necessary for most 
analytes because silylation reactions often progress slowly at room 
temperature).
Usually, heat is applied by mounting the sealed vial in a metallic 
block heated at a prescribed temperature for a prescribed length of 
time or, in alternative, incubating the sealed vial for a few minutes in a 
microwave oven [3,5].
When this process has been completed about 1 micro litre of the 
cooled reaction mixture containing silylated derivatives is injected in 
the GC/MS.
The yield of silylation reactions and, at the end, the nature and 
amount of silylated products, in the reaction mixture which is presented 
to the GC/MS, is controlled and modulated by a plethora of factors 
which comprise the nature of the derivatization agent and solvent, the 
temperature, the length of time and mode of the heat processing [6]. 
For qualitative applications, silylation is generally recognized as the 
most convenient and universal way in which a variety of functionalized 
substances, which as such do not have suitable gas chromatographic 
properties, can be made amenable to gas chromatography.
However, consensus on the usefulness of silylation drops 
dramatically when, in addition, quantification of detected analytes is 
required.
For instance, Villas-Bôas et al. [7], compared the analytical 
performance of silylation with MSTFA and alkylation with methyl 
chloroformate, prior to GC/MS analysis of a number of amino 
and non-amino organic acids, and concluded that alkylation was 
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Abstract
Substitution of polar functionalized compounds with silylated (e.g., trimethylsilylated) surrogates prior to GC/
MS analysis is a widely used analytical strategy. Calibration is a most demanding step of this strategy. In fact, a 
calibration function is usually acquired by converting known amounts of the pure analyte to its silylated surrogate 
using the same conditions employed for processing unknown samples. The cumbersome need of acquiring a new 
calibration function prevents, to a large extend, the possibility of modifying silylation and instrumental settings on a 
sample by sample basis as would be appropriate in a number of cases. The modified standard additions calibration 
method, suggested in this paper, overcomes this difficulty by integrating in a single analytical procedure calibration 
and sample analysis. Furthermore, the suggested procedure compensates for matrix effects which may be a serious 
source of inaccuracy and is a tool that can be used during method development in order to find the most suitable 
silylation conditions for a given analyte. 
The implementation and benefits of the modified standard additions calibration method are explored in this paper 
on the basis of a symbolic but enlightening experiment dealing with the very representative GC/MS quantification of 
biological amino acids via their trimethylsilylated derivatives.
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preferable because of the poorer reproducibility of procedures based 
on trimethylsilylation. 
In practice, derivatization procedures are only an implementation 
of a general and very old principle of analytical chemistry according to 
which a substance to be analyzed is substituted by another substance (a 
surrogate) which is more easily determined than the original substance. 
In abstract, when a surrogate is substituted for the original analyte, 
calibration for quantitative analysis can take place according to one of 
two ways. 
If the surrogate is available as a pure substance and the degree of 
conversion of the original analyte to its surrogate is constant and known 
one can use pure solutions of the surrogate for calibration. 
On the contrary, if the surrogate cannot be isolated in a pure form 
and/or the degree of conversion of the original analyte to its surrogate 
is unknown and is dependent on the particular conditions under which 
substitution takes place, calibration must be performed by converting 
known amounts of the original analyte to its surrogate (using the same 
procedure employed for processing unknown samples). 
Because silylated compounds cannot be isolated and the efficiency 
of silylation procedures is usually unknown, calibration for quantitative 
GC/MS analysis via silylation takes always place by converting known 
amounts of the pure analyte to its silylated surrogate (using exactly 
the same silylation procedure to be employed for the measurement of 
unknown samples).
Obviously, for accurate and reproducible quantitative results, it is 
mandatory that the ratio between the amount of the original substance 
and the amount of its silylated surrogate be maintained constant 
throughout the whole analytical process of calibration and samples 
measurements. 
The weakness of quantitative GC/MS analysis via silylation depends 
entirely on difficulties in maintaining a constant degree of conversion 
of the analyte to its silylated product (or products) both during 
measurement of the calibration function and analysis of unknown 
samples. Among other things, the sample matrix may substantially 
contribute to this difficulty since it is well known that a variety of 
substances (e.g., salts, acids and bases) may influence the yield of 
silylation reactions and then the degree of conversion of an analyte to 
its silylated surrogate [6,7].
In GC/MS, stable isotope dilution analysis elegantly overcomes 
problems connected with the variable degree of conversion of the 
analyte to its surrogate, during calibration and analysis. In fact, isotope 
dilution analysis is a form of internal standardization in which a known 
amount of the stable isotope labelled analyte is added to the sample 
prior to derivatization and analysis and this, in practice, makes each 
analyzed sample auto calibrating [8,9].
Nevertheless, isotope labelled compounds are very expensive or in 
some cases may be unavailable, so much so that the search for alternative 
procedures which can cope with the special problems introduced by the 
silylation step before quantification via GC/MS is a worth undertaking. 
In this paper we describe an analytical procedure, which for 
brevity is indicated as MSAM (modified standard additions method), 
which (as opposed to a rigid protocol to be implemented exactly in the 
same way during calibration and analysis) introduces flexibility on a 
sample by sample basis (since calibration and analysis are integrated 
in a single procedure) and, in addition, has many attributes which can 
improve reproducibility and accuracy of quantification via GC/MS after 
silylation.
In fact, the modified standard additions method is a combination of 
the conventional standard additions and internal standard calibration 
methods which compensate both for matrix effects on the sample 
response (as it is typical of the conventional standard additions 
calibration method) and for the intrinsic erratic nature of the GC/MS 
response (as it is typical of the internal standard calibration method) [10]. 
Within the context of GC/MS quantification via silylation, in our 
laboratory we frequently perform an introductory or preparatory 
GC/MS experiment, called MSAM basic experiment, in which an 
accurately measured volume of the standard solution of the analytes 
to be quantified (which in the frame of the standard additions method 
is used to perform on a given sample the known standard additions) is 
in all respects regarded as the sample to be analyzed using the MSAM 
procedure. Although, at first sight, it may appear odd that a solution 
of the analytes is used in the same experiment as a standard solution 
for calibration and as the sample to be quantified, the MSAM basic 
experiment is very useful to provide the information necessary to 
accurately determine analyte concentration in real samples.
In the following the modified standard additions method is 
presented by carrying out the MSAM basic experiment on a standard 
solution of the biological amino acids. 
Because of their variety and variability of behaviour with respect to 
silylation reactions, biological amino acids hardly can all be determined 
on the basis of a single analytical protocol based on a fixed silylation 
agent, solvent and heat processing. Then, biological amino acids are 
eminently suitable to show the use of the MSAM basic experiment 
and, by extension, the benefits of a sample oriented approach in which 
silylation conditions and instrumental settings can be modified ad 
hoc, case by case, according to the analyst judgment, to target specified 
analytes (without the cumbersome need of collecting a new calibration 
function each time silylation conditions are modified or, for instance, 
when the mass analyzer mode is switched from scan to SIM).
Modified Standard Additions Calibration Method 
(MSAM)
MSAM basic experiment 
The MSAM basic experiment described below and discussed in this 
paper in order to present the modified standard addition method was 
performed using a 100 μM solution of all biological amino acids plus 
Norleucine in 0.05M HCl. 
First, 25 μl of the above standard solution were transferred into 
each of four small vials (labelled Vial0, Vial1, Vial2 and Vial3). 
Then, standard additions of 25 μl, 75 μl and 175 μl of the same 
standard solution of amino acids, were made, respectively, to Vial1, 
Vial2 and Vial3. 
After this, the four specimens in the four vials were carefully dried 
by warming the vials at a temperature of about 60°C under vacuum.
Then, to the anhydrous content of each vial, 25 μl of acetonitrile 
containing 200 μM Naphthalene internal standard and 25 μl of 
BSTFA/1%TMCS silylation reagent were added. 
Finally, the four vials (containing each 50 μl of silylation mixture) were 
tightly sealed, mounted, for the heat processing, on a rotating shaft which 
was immersed in a flux of air heated at about 100°C and kept for one hour.
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At the end of the heat treatment the four vials were cooled, placed 
in a queue and, about 1 μl of reaction mixture was injected, in sequence, 
in the GC/MS which was programmed to execute the GC/MS method 
described below in the scan mode of the mass analyzer and collected 
four GC/MS data file.
For convenience, the GC/MS data file acquired by injecting the 
reaction mixture in VialX will be designed as GC/MSdataX.
Total Ion Chromatograms (TIC) reconstructed from GC/MSdata0, 
GC/MSdata1, GC/MSdata2 and GC/MSdata3 files, acquired in the 
course of the MSAM basic experiment described above, are presented 
in Figure 1. 
In the following we shall also refer to two modified forms of the 
main basic experiment described above. In the basic experiment 
indicated as MW basic experiment, the heat treatment of the main 
basic experiment was replaced with a short heating in a domestic 
microwave oven (5 min at a microwave power output of 800 W) and 
pure BSTFA was substituted for BSTFA/1%TMCS. In a third version of 
the basic experiment, which will be indicated as 4% basic experiment, 
the BSTFA/1%TMCS silylation mixture of the main basic experiment 
was substituted with BSTFA/4%TMCS and a prolonged heat treatment 
(2.5 h) was performed by mounting the four vials in a metallic block 
at 95°C.
In the course of our study of amino acids silylation reactions 
a conspicuous number of experiments on amino acids solutions 
were performed for a variety of purposes and basic experiments 
were replicated several times, although not all data will presented or 
mentioned in the following.
General features of MSAM procedure
In the MSAM basic experiment described above the initial 25 μl of 
standard solution are regarded in all respects as the hypothetical sample 
to be analyzed. 
During the application of the modified standard additions method 
to a real sample, a measured volume of sample is substituted for the 25 
μl of standard solution of the basic experiment. 
Norleucine, which on a real sample is not a biological amino acid 
to be quantified, is used as a pilot compound in the MSAM basic 
experiment and procedure, in a sense that will be explained below. 
Because of this, the MSAM procedure prescribes that, when a real 
sample non containing Norleucine is processed for biological amino 
acids, Norleucine be added in a known and constant amount to each 
of the four vials (using a standard solution of Norleucine). Eventually, 
Norleucine can be substituted with another compound, proved to be 
suitable, when non amino acids analytes are concerned.
The three standard additions of 25 μl, 75 μl and 175 μl performed 
respectively into Vial1, Vial2 and Vial3, transfer into the 50 μl of reaction 
medium, respectively, 50 μM, 150 μM and 350 μM of each amino acid. 
These concentrations are mentioned in the frame of MSAM procedure 
as added concentrations. 
Analogously, the sample transfers to the reaction medium a 
concentration of each amino acid to which we shall refer as reaction 
medium sample concentration. For instance, in the case of the basic 
experiment, 25 μl of the hypothetical sample (which is assume to be 
100 μM in each analyte) transfers to the reaction medium a sample 
concentration of 100·25/50=50 μM. 
In each vial there will be a total concentration of each analyte which 
is the sum of the added concentration and the reaction medium sample 
concentration. 
The reaction medium sample concentration (which coincides 
with the concentration of a given analyte in Vial0) is the most direct 
result of the modified standard additions procedure. The actual sample 
concentration is calculated by multiplying the reaction medium sample 
concentration by the ratio between reaction medium and sample 
volumes. 
Please note that, in all cases, the reaction mixtures in the four 
vials have exactly the same volume and composition, except for the 
concentrations of the analytes in the solution used to make standard 
additions. These are exactly the conditions postulated for the ideal 
operation of the standard additions calibration principle and are 
realized automatically because of the drying step before derivatization. 
By applying existing analysis protocols, in which measurement 
of calibration points and of sample response are nonconcurring, it 
is mandatory a strict control of temperature and time of the heat 
processing during calibration and samples measurements. 
This need is much relaxed by applying MSAM procedure since the 
four vials are processed simultaneously and are exposed automatically 
to the same temperature for the same length of time. 
Although we generally use three standard additions during the 
application of the MSAM procedure, which in our experience are 
generally sufficient and reduce to a minimum work and time for 
an analysis, the number of standard additions is not a mandatory 
prescription of the MSAM procedure and it can be increased in order 
to enhance confidence in the results. 
Materials and Methods
Reagents 
100 μM standard solutions of all 20 biological amino acids plus 
Norleucine were prepared by diluting, with HCl 0.05M, concentrated 
5.000 mM aqueous standard solutions of each amino acid. The 
concentrated standard solutions were prepared by dissolving the 
appropriate reagent grade amino acid (>99%) in 0.05 M HCl and were 
stored at 4°C.
BSTFA (Aldrich 155195; Fluka 15222) and Trimethylchlorosilane 
(Fluka 89595) have been used. 
Naphthalene internal standard and acetonitrile HPLC grade were 
purchased from Carlo Erba Reagents (Italy).
Silylation procedure
Silylation reactions have been performed inside of two ml screw 
top vials with interlocked 300 μl insert (e.g., Supelco 29109-U). Screw 
polypropylene hole caps fitted with double faced PTFE/silicone/PTFE 
septa have been used to prevent leakages of the reaction mixture during 
heat processing (which is detrimental for precision and accuracy) and 
to avoid siloxanes contamination (which takes place if the volatile 
reaction mixture contacts the silicone carrier layer of septa for high 
temperature applications).
The drying step before silylation was performed by maintaining 
vials containing specimens at 60°C under vacuum.
Heat processing was performed either in the conventional way by 
mounting the vials in a heated aluminium block with holes for vials 
Citation: Guida M, Salvatore MM, Salvatore F (2015) A Strategy for GC/MS Quantification of Polar Compounds via their Silylated Surrogates: 
Silylation and Quantification of Biological Amino Acids. J Anal Bioanal Tech 6: 263 doi:10.4172/2155-9872.1000263
Page 4 of 16
Volume 6 • Issue 5 • 1000263
J Anal Bioanal Tech
ISSN: 2155-9872 JABT, an open access journal 
(4% basic experiment), or in a domestic microwave oven (MW basic 
experiment). 
Heat processing during the main basic experiment is based on 
an in house built device constituted by a shaft, with houses for vials, 
which can be rotated at a selectable speed; the rotating vials are exposed 
to a stream of air heated at a selectable temperature (50-120°C) for a 
selected time interval; when the prescribed time is expired the warm 
air flux automatically turns to cold air (~10°C) while the shaft keeps 
rotating so that the vials are efficiently cooled. This configuration of 
the heat treatment provides continuous stirring of the reaction mixture 
which favours silylation reactions.
GC/MS method
All data presented in the following were acquired on an Agilent GC/
MS system consisting of the 6850 GC and 5973 Inert MSD controlled 
by the Agilent ChemStation data system. 
The GC was equipped with a HP5MS capillary column (30 m, 0.25 
mm, 0.25 μm) and ultra-high purity helium was used as a carrier at a 
flow rate through the column of 1 ml/min. 
The split/splitless injector was held at 250°C. The oven initial 
temperature was 70°C (hold 1 min) and was programmed to ramp to 
170°C at 10°C/min; then was ramped to 280°C at a rate of 30°C/min 
and held for 5 min. The total run time for each acquisition was 19.66 
min but, in general, all silylated amino acids were eluted in about 15 
minutes. 
The electron impact (EI) ion source was operated at 70 eV and at 
200°C. The quadrupole mass filter was kept at 250°C and, in the scan 
mode, was programmed to scan the range 45-550 Th at a frequency of 3.9 Hz. 
In order to keep retention times reproducible (so that they can be 
used for identification in addition to mass spectra) the GC/MS method 
was locked on anthracene at 12.500 min [11].
Discussion and Results
Basic MSAM data analysis 
In the application of MSAM procedure, reviewing the data in GC/
MSdata0 file is of the outmost importance since only analytes whose 
surrogates can be detected from this data file are deemed to be present 
in the sample and eventually submitted to quantitative evaluation. 
Labels in Figure 1 must be interpreted as placeholders roughly 
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Figure 1: Total Ion Chromatograms (TIC) acquired by injecting the four silylation mixtures of the basic experiment described in the text. Label for Trp4TMS (not 
visible) is at 17.856 min.
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indicating the expected retention time of the indicated amino acid 
derivative as deduced by silylating and analyzing, with the same GC/
MS method, pure solutions of each amino acid under a variety of 
silylation conditions.
There is no label for Histidine derivatives since we have never 
succeeded in preparing detectable amounts of any of the expected 
trimethylsilyl derivatives of this amino acid. This is somewhat puzzling 
since, for instance, in ref. [14], Histidine is reported to be silylated to 
His2TMS, in an aqueous plant extract, after a short heat treatment in 
a microwave oven (3 min at 180 W), although the exact reagents and 
amounts are not mentioned in the publication. 
Apart from that, visual inspection of the TIC reconstructed from 
GC/MSdata0 file (first chromatogram in Figure 1) shows that most 
of the labels correspond to well-developed peaks. Obviously, this is 
interpreted as a strong indication that the corresponding derivative was 
present in the injected mixture and it is confirmed on the basis of the 
mass spectrum. 
In practice, GC/MSData0 file was conveniently searched for amino 
acids trimethylsilylated derivatives using the NIST program AMDIS 
(Automated Identification and Deconvolution System) [12] (http://
chemdata.nist.gov/mass-spc/amdis/downloads/) and a custom MS 
target library with mass spectra and retention times of an assortment of 
amino acids silylated derivatives acquired by silylation of pure solutions 
of amino acids under a variety of conditions (using the GC/MS method 
described above) [13]. 
AMDIS analysis of GC/MSdata0 file identified, in a matter of 
seconds, all derivatives which have a label in Figure 1, except Asn3TMS, 
Lys3TMS, Lys4TMS, Tyr3TMS, Orn4TMS, Trp3TMS and Trp4TMS. 
From this we conclude that these amino acids derivatives have 
not been produced in detectable amounts under the conditions of 
the basic experiment and, by consequence, cannot be employed for 
quantification of the corresponding amino acid (although the fact that 
a label is present in Figure 1 implies that under different conditions the 
corresponding derivative has been produced in detectable amounts).
In order to avoid interferences from coeluting substances and from 
ions in the background and ambiguities in integrating overlapping 
peaks, for each amino acid, an extracted ion chromatogram (EIC) at the 
mass of a selected target ion characteristic of the amino acid silylated 
derivative has been used for quantification. 
Targets ions for each of the silylated amino acids which have a 
label in Figure 1 are presented in Table 1 (where also are reported the 
expected retention times of each derivative and of Naphthalene internal 
standard).
For instance, in Figure 2, it is presented the EIC at m/z=232.2 Th 
(which corresponds to the target ion of Asp3TMS surrogate of Aspartic 
Acid) extracted from GC/MSdata0 file. As can be seen, there is a peak 
in the EIC at 10.638 min which is very close to the expected Asp3TMS 
derivative retention time. 
Please note that, although in the TIC peak of Asp2TMS overlaps 
with peak of Met2TMS surrogate of Methionine and with peak of 
PyrGlu2TMS surrogate of Glutamine and Glutamic Acid (see discussion 
in the next paragraph), no overlapping can be seen in Figure 2, simply 
because neither Met2TMS nor PyrGlu2TMS produce fragments at 232 Th.
Furthermore, the standard additions calibration method principle 
requires, for accurate results, that the background be subtracted from 
the analyte response and this is, in general, automatically obtained by 
using the integrated signal in the EIC which ascend from a practically 
null background. 
Then, the EIC peak of Asp2TMS is integrated without ambiguities 
and the area under this peak represents the primordial experimental 
datum for quantification of Aspartic Acid through its Asp2TMS 
surrogate. 
However, using the target ion EIC for quantification does not 
suppress the intrinsic variability of the GC/MS response which would 
be the cause of irreproducibility. 
For this reason (as it is typical of the internal standard calibration 
method), the normalized ratio between the absolute area under the 
peak of each target ion and the area under the peak of Naphthalene 
target ion at m/z=128.15 Th has been used for quantification (instead of 
the absolute EIC response).
Amino Acid
trimethylsilyl
derivative
RT(min) Target Ion(Th)
Amino Acid
trimethylsilyl
derivative
RT(min) Target Ion(Th)
Ala2TMS 5.306 116.15 Phe1TMS 10.858 120.10
Gly2TMS 5.495 102.10 Cys3TMS 10.957 220.20
Naphthalene 
IS 6.470 128.10 Glu3TMS 11.445 246.20
Val2TMS 6.779 144.15 Phe2TMS 11.513 192.20
Leu2TMS 7.524 158.15 Asn3TMS 11.848 116.10
Ile2TMS 7.817 158.15 Lys3TMS 12.110 84.10
Pro2TMS 7.864 142.20 Orn3TMS 12.608 142.00
Gly3TMS 7.990 174.15 Lys2TMSmethyl ester 12.766 174.00
Nor2TMS 8.174 158.20 Tyr2TMS 12.923 179.15
Ser3TMS 8.708 204.20 Tyr3TMS 13.059 218.20
Thr3TMS 9.081 218.2 Lys4TMS 13.070 174.15
Met2TMS 10.611 176.20 Trp2TMS 14.186 202.15
Asp2TMS 10.637 232.20 Trp3TMS 14.210 202.15
PyrGlu2TMS 10.653 156.20 Trp4TMS 17.856 202.15
Table 1: Target ions and expected retention times of amino acids trimethylsilyl 
derivatives and Naphthalene internal standard.
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Figure 2: Extracted Ion Chromatogram (EIC) of trimethylsilylated Aspartic 
Acid derivative, Asp3TMS, at 232.20 Th. The integrated peak at 10.638 
min represents the primordial absolute response of Aspartic Acid used for 
quantification.
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Please note that Naphthalene internal standard has been introduced 
at the same concentration in all reaction mixtures through the solvent.
Finally, from each of the four GC/MSdataX files, for each of 
the amino acids derivatives detected in the sample, a number is 
calculated, which for brevity will be called the target ion response ratio 
(TargetIonRR), representing the ratio of the area under the peak of its 
target ion and the area under the peak at m/z=128.15 Th of Naphthalene. 
In practice, TargetIonRR are calculated by using the standard 
resources of GC/MS data system which, if suitably programmed, takes 
care of integrating the EIC peaks of targets and internal standard and 
then calculates their ratio.
From the four acquisition of the MSAM procedure, four target 
ion response ratios have been obtained for each detected amino acid 
derivative. Then, each target ion response ratio has been coupled with 
the corresponding calculated added concentration in the reaction 
mixture (0 μM, 50 μM, 150 μM and 350 μM) so that, finally, for 
each silylated derivative detected, a standard additions plot with four 
(TargetIonRR, AddedConc) experimental points can be constructed 
(plotting the four target ion response ratios as a function of the added 
concentrations).
In the present case, as can be seen from the first column of Table 
2, 20 amino acids silylated derivatives, corresponding to 18 different 
amino acids have been detected in the GC/MSdata0 file so that, in 
abstract, 20 different standard additions plots can be constructed. 
The hope is that the four points of each plot fall on a straight line 
since it is the extrapolated intercept, on the concentration axis, of the 
regression line through the experimental points, which is of analytical 
significance in the modified standard additions method. 
The usefulness of the basic experiment depends on the fact that, 
as a consequence of the fact that sample and standard solution used 
for standard additions share exactly the same concentrations, the 
intercept of the regression line through the (TargetIonRR, AddedConc) 
experimental points on the x-axis is fixed a priori exclusively from 
the assumed concentrations of the amino acids and their actual 
concentrations in the sample and standard solution are completely 
irrelevant. So much so that we can a priori state that, if all the 
fundamental assumptions on which quantification via a surrogate of the 
analyte rests are maintained during the experiment, the (TargetIonRR, 
AddedConc) experimental points in the standard additions plots 
of all analyte must be well fitted by a straight line which, within the 
uncertainties introduced through volume manipulations and response 
measurements, intercepts the added concentrations axis at -50 μM. 
Any departure from this fundamental a piori condition must be 
interpreted as a warning that assumptions have been violated (and 
cannot be ascribed to inaccuracies of the analytical variables).
Interpretation of standard additions plots from MSAM basic 
experiment
Interpretation of data from the MSAM basic experiment (which 
is employed to prove that silylation and measurement conditions 
are appropriate for a given analyte) is fundamentally based on a very 
special function assigned to Norleucine. 
This special role has been conferred to Norleucine following a 
conspicuous number of ad hoc silylation experiments which have 
demonstrated that Norleucine is readily and consistently silylated to 
Nor2TMS with BSTFA and BSTFA/TMCS silylation agents, provided 
that broadly reasonable derivatization conditions are maintained. 
This anticipated very desirable behaviour of Norleucine is clearly 
demonstrated in Figure 3 which is the standard additions plot of 
Nor2TMS constructed from data from the main basic experiment.
As can be seen from Figure 3, experimental (TargetIonRR, 
AddedConc) points are almost perfectly interpolated by a straight 
Amino Acid
TMS
derivative
Slope
(μM-1)
Response
axis
intercept
R2
Calculated concentration in 
the standard
solution(μM)
Not
reviewed Reviewed
Nor2TMS 1.095E-02 5.547E-01 0.999 101.4 accepted
Leu2TMS 1.058E-02 5.375E-01 0.999 101.6 accepted
Ala2TMS 7.45E-03 3.848E-01 0.999 103.3 accepted
Gly2TMS 2.30E-03 1.075-01 0.971 93.4 rejectedsee text
Gly3TMS 3.00E-03 1.436E-01 0.986 95.6 rejectedsee text
Val2TMS 8.71E-03 4.55E-01 0.995 104.5 accepted
Ile2TMS 9.16E-03 5.33E-01 0.999 103.5 accepted
Pro2TMS 9.18E-03 4.108E-01 0.997 89.5 96.8
Ser3TMS 6.95E-03 3.302E-01 0.997 95.0 accepted
Thr3TMS 3.333E-03 1.583E-01 0.994 95.0 accepted
Met2TMS 4.87E-03 2.295E-01 0.998 94.2 accepted
Asp2TMS 5.86E-03 3.029E-01 0.993 103.4 accepted
PyroGlu2TMS 9.70E-03 5.274E-01 0.995 108.7 103.9
Glu3TMS 3.06E-03 1.63E-02 0.993 10.65 rejectedsee text
Phe1TMS 1.25E-03 7.093E-02 0.998 113.4 rejectedsee text
Phe2TMS 4.16E-03 1.448E-01 0.997 69.6 rejectedsee text
Lys2TMS ME 6.57E-3 2.36E-1 0.949 71.84 rejectedsee text
Cys3TMS 1.48E-3 1.89E-01 0.949 255.4 rejectedsee text
Tyr2TMS 6.99E-03 2.46E-01 1.000 70.39 rejectedsee text
Trp2TMS 1.015E-03 2.201E-02 0.983 43.4 rejectedsee text
Table 2: Equations of the regression line through the (TargetIonRR, 
AddedConc) experimental points in the standard additions plots and 
calculated concentrations of the standard 100 μM solution of amino acids 
(data from the main basic experiment in Figure 1). Only concentrations 
which are affected by an uncertainty (evaluated from the standard additions 
plot) which does not exceed the set threshold of ± 6% have been accepted. 
 
y = 0.01095x + 0.5547R² = 0.999
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Add.2: 75 μl μl ↳150 μM
Add.3: 175 μl μl ↳350 μM
Figure 3: Modified standard additions plot for Norleucine2TMS (target ion 158.2 
Th; data from the main basic experi-ment in Figure 1). Experimental points are 
interpolated with a least square regression line whose equation is given in the plot. 
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regression line which intercepts the concentration axis at -50.7 μM. This 
is interpreted to mean that the reaction medium sample concentration 
of Norleucine is found to be 50.7 μM, which can be compared with 
the a priori known value (50 μM). From this value the concentration 
of Norleucine in the standard solution is readily calculated to be 
50.7(50/25)=101.4 μM.
Because of the proved almost ideal behaviour of Norleucine 
with respect to silylation reactions, we may infer that dispersion 
of experimental points around the regression line in the standard 
additions plot of Nor2TMS is completely ascribable to unavoidable 
casual variations of volumes and response measurements. 
Since these sources of dispersion are exactly the same for all analytes 
submitted to the MSAM basic experiment, dispersion of experimental 
points in the standard additions plot of an analyte, exceeding the 
physiological dispersion exposed by the standard additions plot of 
Norleucine, must be ascribed to chemical factors connected with the 
efficiency of silylation reactions.
In other words, during the analysis of the MSAM basic experiment 
data, we consider the standard additions plot of Norleucine in Figure 
3 as a milestone signing the boundary beyond which chemical effects 
must be invoked to explain observed dispersion of experimental points.
Experimental points’ dispersion around the standard additions 
regression line can be measured in a variety of ways. However, in order 
to be practical, we have selected the standard error on the intercept 
of regression line on the x-axis, symbolized by ESx, as a measure of 
the spread of the experimental points. In fact, ESx has a very direct 
analytical significance and is readily evaluated from the coordinates of 
the experimental points, for instance, with the ERR.STD.YX function 
of MS Excel.
For instance, from data in Figure 3 we obtain ESx ≈ 3 μM which 
can be translated into a relative percent uncertainty on the reaction 
medium sample concentration of Norleucine of ~ ± 100·3/50.7 ≈ ± 6%.
Finally, on the basis of the above considerations, we take the broad 
view that an uncertainty on reaction medium sample concentration 
of an analyte (derived from its MSAM basic experiment standard 
additions plot) substantially exceeding the ± 6% threshold deduced 
from Figure 3, is a warning of possible violations of fundamental 
constraints of chemical analysis via surrogate due to badly chosen 
silylation conditions. 
The role of the Norleucine during the analysis of unknown samples 
is much simpler, since in such a case it is assumed that silylation 
conditions appropriate for the targeted analytes have been employed 
and inspection of Norleucine MSAM standard additions plot only 
serves as a general control that the MSAM procedure has been 
properly carried out. In fact, as a general rule, if satisfying results are 
not obtained for Norleucine, hardly they will be obtained for any other 
analyte. Apart from that, MSAM standard additions plots of analytes 
are evaluated during analysis of real samples exactly as conventional 
standard additions plots [10]. 
To touch by hand how the above statements operate in interpreting 
data from the basic experiment, the standard additions plot for 
Pro2TMS surrogate of Proline (calculated from data in Figure 1) is 
presented in Figure 4.
A brute linear regression through the (TargetIonRR, AddedConc) 
experimental points, as for Norleucine, produces a reaction medium 
sample concentration of Proline of 44.5 μM which, obviously, is 
substantially lower than expected, even if Proline has been submitted 
exactly to the same events as Norleucine. Furthermore, the reaction 
medium sample concentration of Proline determined from the 
standard additions plot is affected by an uncertainty (~ ± 20%) which 
is much higher than the threshold of ~ ± 6% derived from the standard 
additions plot of Norleucine. This is interpreted to mean that there 
must be a problem in the data. The problem is seen at blink of an eye 
from Figure 4, and it concerns the measured target ion response ratio 
of Pro2TMS in Vial2 (corresponding to an added concentration of 150 
μM). It seems that, for unknown reasons, the fraction of Proline which 
has been converted to Pro2TMS in Vial2 is lower and inconsistent with 
the silylation efficiency in other vials. 
In fact, from Figure 4 we see that the broken line, which is the 
regression line calculated by excluding this point, intercepts the x-axis at 
-48.0 μM with an uncertainty which is much under the threshold of ± 6%. 
The lesson we learn from this is that Proline could be more 
susceptible than other amino acids to even minimal alterations either 
of the reaction medium environment or of the physical processing. 
In this respect it is useful to remember that the composition of the 
reaction medium is very complex with dozens of chemical species 
simultaneously present.
The above example helps in the interpretation of Table 2 which 
presents, for each amino acid, the equation of the regression line 
through the experimental (TargetIonRR, AddedConc) points in the 
standard additions plot (derived from a brute linear interpolation of data) 
and the corresponding calculated concentration in the standard solution. 
The outcomes of a critical revision of standard additions plots, on 
an amino acid per amino acid basis (as exemplified for Proline), are 
reported in the <Reviewed> column of Table 2. Only concentrations 
derived from standard additions plot for which the standard error on 
the intercept on the x-axis does not substantially exceed the set ± 6% 
threshold have been accepted. From Table 2 one can see that a number 
of amino acids concentrations have been rejected. 
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Figure 4: Modified standard additions plot for Proline2TMS (target ion 142.2 
Th; data from the main basic experiment in Figure 1). Experimental points are 
interpolated with a least square regression line whose equation is given in the 
plot (solid line). The broken line is the regression line calculated by excluding the 
experimental point at an added concentration of 150 μM.
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Justifications for rejections are the most instructive part of the basic 
experiment and are presented below. 
Lysine, Tyrosine and Tryptophan standard additions plots
Trimethylsilylation usually involves substitution of H atoms on 
oxygen, nitrogen, sulphur, etc., with trimethylsilyl, -Si(CH3)3, groups. 
However, under certain conditions, unexpected derivatives are formed. 
These unexpected derivatives are mentioned as artifacts.
Derivatization of pure Lysine solutions with BSTFA/1%TMCS 
produces bis(trimethylsilyl)-Lysine methyl ester (Lys2TMS methyl 
ester) artifact of Lysine:
O
O
NH
NH
Si
CH3
CH3
CH3
Si
CH3
CH3
CH3
CH3
Bis(trimethylsilyl)-Lysine methyl ester 
(Lys2TMS methyl ester)
Under the conditions of the basic experiment, Lysine methyl 
ester artifact is the only derivative of Lysine which is detected and, by 
consequence; it is used as the surrogate for Lysine quantification. 
Lys2TMS methyl ester is easily recognized from GC/MSdata0 
file from the peak at 12.766 min in the EIC at 174 Th (which are, 
respectively, the retention time and the target ion of Lys2TMS methyl 
ester) and the corresponding mass spectrum (Figure 5). 
As expected, EIC peaks at 174 Th and 12.766 min grow in an 
apparently regular way after additions of the standard solution. 
One can see from the standard additions plot in Figure 6A, that 
experimental (TargetIonRR, AddedConc) points fall, at first sight, on 
a straight line and this is taken as an indication that our assumptions 
are correct. 
However, the regression line in Figure 6A extrapolates to -35.9 
μM and the uncertainty of the calculated reaction medium sample 
concentration of Lysine is evaluated to be about ± 13%. From our point 
of view these values, which deviate substantially from the expected 
values, are symptoms that under the conditions of the basic experiment, 
not all fundamental assumptions on which interpretation of the 
experiment is based are maintained for Lysine. 
The problem with Lysine becomes apparent if, in Figure 6A, we 
draw a line through the experimental point at an added concentration 
of 350 μM of Lysine (corresponding to the largest standard addition) 
and force this line through the abscissa at - 50 μM which, in the basic 
experiment, is the a priori known intercept of all regression lines 
(broken line in Figure 6A). 
After this, we see from Figure 6A that all the experimental points 
calculated from GC/MSdata0 (the sample), GC/MS/data1 (first 
standard addition), GC/MSdata2 (second standard addition) fall under 
the broken line and the distance of experimental points from the broken 
line increases by decreasing Lysine concentration. 
Hardly one can escape the suggestion that, under the conditions of 
the basic experiment, the fraction of Lysine which has been converted 
to its surrogate is not exactly the same in all four vials but, apparently, 
increases (although very little) as its concentration in the reaction 
medium is increased. 
In other words, under the conditions of the present experiment, 
points at low concentrations lag behind points at high concentrations 
and trudge toward the expected position in the plot.
The fundamental effect of this phenomenon is that regression 
lines through experimental points have higher slopes and less negative 
intercepts on the concentration axis.
When using the conventional internal standard method for 
calibration, the described effect may produce internal standard 
calibration lines with a negative intercept on the response axis. For 
instance, in ref. [15], under silylation conditions similar to those of 
the main basic experiment, an internal standard calibration line with a 
negative intercept on the y-axis is obtained for Lysine.
In order to support this explanation we present in Figure 6B the 
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Figure 5: (A) Mass spectrum extracted at 12.766 min from GC/MS0 file of the 
main basic experiment. (B) Extracted Ion Chromatograms at 174 Th extracted 
from GC/MSfile0, GC/MSfile1, GC/MSfile2, GC/MSfile3 showing peaks at a 
retention time corresponding to the expected retention time of Lysine2TMS 
methyl ester artifact. Chromatograms are shifted along the time axis for clarity.
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between the slower response at the lowest concentrations and the 
faster response at the highest concentrations of Lys2TMS methyl ester 
artifact should be enhanced. From Figure 6B, we see that, in effect, the 
fraction of Lysine which is converted to its surrogate is actually very 
low at the lowest concentrations and suddenly increases at the highest 
concentrations. Furthermore, note as the response of Lysine2TMS 
methyl ester artifact is much lower in the MW experiment compared to 
the basic experiment. Although in Figure 6B a regression line is drawn 
through the experimental points, it is clear that it cannot be accepted 
since the response practically does not increase at all after the first 
standard addition and even because, after all, it has a positive intercept 
on the concentration axis.
In general, the described effect can be overcome either by allowing 
a longer heat processing in order for points at the lower concentrations 
to catch up with points at the highest concentrations and/or by using 
as silylation reagent BSTFA enriched with several percents of TMCS, 
although these conditions may be not favourable for other amino acids. 
As can be deduced from the low concentrations of Tyrosine and, 
especially, Tryptophan reported in Table 2, standard additions plots 
of Tyr2TMS and Trp2TMS also may be affected by this very insidious 
inconsistency of points at low concentrations which do not catch up 
with points at high concentrations, so much so that a dependence of 
the response from the square of concentration may be simulated (as can 
be deduced from the standard additions plot of Trp2TMS in Figure 7). 
Finally, from the present experiment we learn the lesson that 
we have to be very vigilant toward the inset of this very insidious 
inconsistency between points at low concentrations which apparently 
require more time to reach the same degree of conversion of points at 
higher concentrations. 
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Figure 6: (A) Modified standard additions plot for Lysine2TMS methyl 
ester (target ion 174 Th; data from the main basic experiment in 
Figure 1). Experimental points are interpolated with a least square 
regression line whose equation is given in the plot (solid line). (B) 
Same as in (A) but using data from the MW basic experiment. 
In both cases, the broken lines are drawn through the experimental point at an 
added concentration of 350 μM and are forced to intercept the abscissa at -50 
μM in order to stress inconsistency between points within the calibration curve.
standard additions plot of Lys2TMS methyl ester calculated from data 
acquired during the MW basic experiment. 
Because the heat treatment in a microwave oven is much shorter 
(5 min in the present case) and no TMCS is used, the differences 
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Figure 7: Modified standard additions plot for Tryptophan2TMS (target ion 
202.15 Th; data from the main basic experiment in Figure 1). Experimental points 
are interpolated with a least square regression line whose equation is given in 
the plot (solid line). The broken line is drawn through the experimental point at 
an added concentration of 350 μM and is forced to intercept the abscissa -50 
μM in order to stress inconsistency between points within the calibration curve.
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Apart from that, from Table 2 one can see that the concentrations 
of Lysine, Tyrosine and Tryptophan, calculated from standard additions 
plots, have been rejected, simply because they have uncertainties which 
do not comply with the set threshold. 
Cysteine standard additions plots
From Table 2 we see that for Cysteine a much larger concentration 
(255 μM) than expected and the lowest determination coefficient (0.949) 
is obtained performing a brute linear interpolation of experimental 
(TargetIonRR, AddedConc) points. 
The standard additions plot for Cysteine, calculated from data 
acquired in the main basic experiment, is presented in Figure 8A.
In this case, one can see at the blink of an eye that the experimental 
(TargetIonRR, AddedConc) data points are not well fitted with a 
straight line and this is, in the modified standard additions strategy, in 
and by itself, a sufficient reason for rejecting the results. In fact this is 
a clear indication that the procedure employed is not suitable for the 
consistent silylation of Cysteine to its Cysteine3TMS surrogate.
Obviously, one would like to know what it is the problem with 
Cysteine in order to modify the procedure consciously.
For this, we make use, once again, of the fact that we know a priori, 
in the basic experiment, that the proper regression line must necessarily 
intercept the abscissa at -50 μM. Then, virtually, we take a line through 
the point (TargetIonRR=0, AddedConc=-50 μM) and rotate this 
line in an attempt to find a slope which gives an acceptable fit of the 
experimental points. 
In applying this hypothetical procedure we certainly would get 
impressed by the broken line in Figure 8A. This broken line gives a 
perfect fit for the two experimental points corresponding to added 
concentrations of 0 μM (sample) and 50 μM (first standard addition). 
Points corresponding to the second and third standard additions fall 
under this broken line. 
Hardly one can escape the suggestion that the amount of Cys3TMS 
in Vial2 and Vial3 is much lower and inconsistent with Cys3TMS 
content of other vials. 
In other words, either the yield of the Cysteine silylation reactions 
decreases with concentration or Cys3TMS, whose response is 
measured, disappears from the injected solution at a faster rate as the 
concentration is increased.
The first hypothesis is not very likely, since, as we have shown 
above, and as it is reasonable, the rate of silylation reactions tends to 
be enhanced by increasing the concentration of the amino acid in the 
reaction medium. 
Then we are left with the idea that Cys3TMS is created consistently 
in all vials but could be unstable in the very complex chemical 
environment of the silylation mixture with respect to side reactions that 
produce more stable not detected products. 
In Figure 8B it is shown the standard additions plot for Cys3TMS 
obtained from the MW basic experiment. The MW basic experiment 
has a time scale much shorter than the main basic experiment so that 
the effect of any side reaction should be minimized. Furthermore, 
in this experiment each solution in Vial0, Vial1, Vial2 and Vial3 was 
injected twice.
In the direct experiment we acquired four data files injecting the 
reaction mixture in the usual order from Vial0 to Vial3. Then, after 
about one hour, we reinjected the reaction mixtures in the reverse order 
(from Vial3 to Vial0).
From Figure 8B we see that the (TargetIonRR, AddedConc) 
experimental points acquired in the direct runs are well fitted with a 
straight line (solid line in Figure 8B) which now intercepts the abscissa 
at -48.4 μM which is within the set precision threshold from the 
expected value.
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Figure 8: (A) Modified standard additions plot for Cysteine3TMS (target ion 
220.2 Th; data from the main basic experi-ment in Figure 1). The broken 
line is drawn through the experimental points at added concentrations 
of 0 μM and 50 μM and is forced to intercept the abscissa -50 μM. (B) 
Modified standard additions plot for Cysteine3TMS (data from the MW 
basic experiment). Reaction mixtures were injected twice, respectively, in 
direct order from Vial0 to Vial4 (solid line) and in reverse order (broken line).
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(TargetIonRR, AddedConc) points acquired in the reverse runs, 
tend generally to fall under the corresponding points of the direct 
runs but the distance decreases by decreasing concentration and the 
TargetIonRR of the sample is practically the same in the two runs. As 
can be seen also the (TargetIonRR, AddedConc) experimental points 
acquired in the reverse run are fitted by a straight line which intercepts 
the abscissa at a concentration very close to that expected, but the 
reaction medium sample concentration calculated from the reverse run 
cannot be accepted because of a higher than expected uncertainty. 
Evidently, Figure 8, considered in its entirety, supports the idea that 
Cys3TMS may be unstable under many silylation conditions in which 
a prolonged heat processing is employed (particularly at the highest 
concentrations) especially if, in addition, the fact that an increased 
response was recorded, in the reverse runs, for most of the amino acids 
is attached. 
Glycine standard additions plots
Glycine, under the conditions of the basic experiment and, in 
general, under most silylation conditions, is detected as a mixture of 
Glycine2TMS and Glycine3TMS derivatives so that two standard 
additions plots can be drawn. If the fundamental constraints of analysis 
via a surrogate (namely that a constant fraction of Glycine is converted 
to Gly2TMS and a constant fraction is converted to Gly3TMS) is 
maintained for all silylated solutions, then we should obtain the 
reaction medium sample concentration of Glycine both from the 
standard additions plot for Gly2TMS and for Gly3TMS. 
The two standard additions plots for Gly2TMS and Gly3TMS 
surrogates of Glycine (constructed from data from the main basic 
experiment in Figure 1) are shown in Figure 9, in which are also drawn 
regression lines, through the experimental (TargetIonRR, AddedConc) 
points, calculated by a straight interpolation procedure.
Intercepts on the x-axis are - 46.7 μM and - 47.8 μM respectively 
from Figure 9A and 9B and they agree within 2%. 
However, the reaction medium sample concentrations calculated 
from these plots have a much lower precision than expected (± ~ 30%), 
because of the excessive spread of points around the regression line. 
In fact, even a superficial inspection of Figure 9 will show that 
we have not been completely successful in maintaining throughout 
the whole sequence of measurements a constant conversion factor 
from Glycine to its surrogates and the fact that the intercepts of the 
regression lines in Figure 9A and 9B are very close to each other is a 
mere coincidence.
For instance, it is clear from Figure 9 that in the reaction mixture 
in Vial2 (corresponding to an added concentration of 150 μM) a larger 
fraction of Glycine was converted to Gly3TMS and a lower fraction to 
Gly2TMS compared to other vials. 
This is not unexpected since the problem with Glycine is just that 
the Gly2TMS derivative is slowly converted, both at high and room 
temperature, to Gly3TMS.
We can regard the formation of Gly3TMS as a side reaction of 
Gly2TMS so that, as in the case of Cysteine, difficulties should be 
overcome by a short heat treatment which is suitable to minimize the 
effect of side reactions.
In fact, as expected, Glycine is detected almost exclusively as 
Gly2TMS derivative in the MW basic experiment, as it is shown in 
Figure 10A which is the TIC of the reaction mixture in Vial0 acquired 
during the microwave experiment. 
Under the silylation conditions of the microwave experiment 
Glycine can be treated essentially as other amino acids for which a 
single derivative is detected as can be deduced from the standard 
additions plot in Figure 10B. 
Obviously, when only a small fraction of Glycine is converted to its 
Gly3TMS surrogate, as in the case considered in Figure 10, the standard 
additions plot for Gly3TMS cannot be used since the low concentration 
of Gly3TMS in the reaction mixture is easily modified by the conversion 
Gly2TMS→Gly3TMS and it is, by consequence, erratic.
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Figure 9: Modified standard additions plots for Glycine2TMS (target ion 102.10 
Th) and Glycine3TMS (target ion 174.15 Th) calculated from data acquired 
during the main basic experiment. Experimental points are interpolated 
with a least square regression line whose equation is given in the plot. 
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Phenylalanine standard additions plots
Silylation of Phenylalanine with BSTFA and BSTFA/TMCS gives 
results superficially similar to those of Glycine because two silylated 
derivatives, Phe1TMS and Phe2TMS are discovered under most 
silylation conditions. 
As in the case of Glycine, we can use either the standard additions 
plot of Phe1TMS or the standard additions plot of Phe2TMS, or both, 
for quantification and these are presented in Figure 11.
As can be seen from Figure 11, there is a substantial difference 
between the intercepts of the two regression lines in the standard 
additions plot of Phe1TMS and Phe2TMS. 
In addition, the calculated reaction medium sample concentrations 
have a much higher uncertainty, about ± 25%, than the set threshold. 
Obviously, this is a warning that some inconsistency exists between 
the experimental points although it is not easily discovered. 
On this basis both the Phenylalanine concentrations calculated 
from standard additions plots in Figure 11 have been rejected (Table 2). 
Unfortunately the above inconsistency is not resolved and the 
pattern in Figure 11 is replicated both using data from the MW and 
from the 4% basic experiment which, in addition, are not even helpful 
for clarifying the chemical reasons for this inconsistency affecting 
Phenylalanine silylation.
Glutamine and Glutamic acid standard additions plots
Glutamine and Glutamic Acid produce, as a common artifact, 
bis(trimethylsilyl)-Pyroglutamic Acid (i.e., PyrGlu2TMS) which is 
discovered in the TIC as a well-developed peak after silylation with 
BSTFA and BSTFA/TMCS mixtures (Scheme 1).
In addition, under many silylation conditions, the regular derivative 
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Figure 10: (A) Total Ion Chromatogram of the sample (Vial0) acquired during the MW basic experiment. (B) Modified standard additions plots for Glycine2TMS 
(target ion 102.10 Th) calculated from data acquired during the MW basic ex-periment.
of Glutamic Acid (i.e., Glu3TMS, whose mass spectrum exposes a weak 
mass peak of the parent ion at an odd mass and it is dominated by an 
even mass fragment at 246 Th), can also be detected. The expected 
regular derivative of Glutamine (i.e., Gln3TMS, whose mass spectrum 
should expose a molecular ion of even mass) has not so far been 
reported. It is possible that Glutamine is converted to Glutamic Acid 
during the silylation procedure, because silylation with BSTFA and 
BSTFA/TMCS of solutions of pure Glutamine gives a weak peak which 
can be identified as Glu3TMS [16].
Because two separated derivatives of Glutamine and Glutamic Acid 
are never detected, it will be, in general, impossible from the TIC of an 
unknown sample, to distinguish cases in which both Glu and Gln are 
present from cases in which only one of them is present. Furthermore, it 
is not surprising, after all, that quantification of Glutamic Acid through 
its regular derivative Glu3TMS does not give reliable results (Table 2). 
Then, the only practicable analytical strategy is to aim at the 
determination of the sum of Glu and Gln concentrations through the 
response of their common PyrGlu2TMS surrogate (which is always well 
developed) by using for standard additions a solution which contains 
both Glutamic Acid and Glutamine. 
Obviously, to this end, the best would be to employ a silylation 
procedure that allows complete conversion of Glu and Gln to 
PyrGlu2TMS.
This can be obtained by employing as silylation reagent BSTFA 
enriched with several percents (e.g., 4%) of TMCS and maintaining 
the reaction mixture for a time longer than usual (e.g., 2-3 hours) at a 
temperature of 90-100°C.
This is demonstrated in Figure 12A which presents the TIC 
reconstructed from the GC/MSdata0 file acquired during the 4% basic 
experiment (in which no Glu3TMS is detected).
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The standard additions plot for PyrGlu2TMS, constructed from data 
collected during the 4% basic experiment, is presented in Figure 12B.
Please note that the largest standard addition in the 4% basic 
experiment has been reduced to 75 μl which corresponds to an added 
concentration of Glu plus Gln of 300 μM in 50 μl of reaction medium.
The intercept of regression line in Figure 12B matches, within the 
set precision threshold, with the a priori known value (100 μM). 
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Scheme 1: Pyroglutamic Acid artifact of silylation of Glutamine and 
Glutamic Acid with BSTFA and BSTFA/TMCS, regular expected 
trimethylsilyl derivatives and base ion of the mass spectrum of Glu3TMS.
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Figure 11: Modified standard additions plots for Phenyalanine1TMS (target 
ion 120.1 Th) and Phenylalanine2TMS (target ion 192.2 Th) calculated from 
data of the main basic experiment. Experimental points are interpolated 
with a least square regression line whose equation is given in the plot. 
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Figure 12: (A) TIC reconstructed from GC/MSdat0 file of the 4% basic experiment. 
(B) Modified standard additions plot for PyrGlu2TMS (target ion 156.2 Th) 
calculated from data collected in the 4% basic experiment. Added concentrations 
refer to the sum of Glutamine and Glutamic acid concentrations. The expected 
intercept of regression line on the concentration axis is 200·25/50=100 μM which 
represents the sum of Glu and Gln concentration in the reaction medium (50 μl).
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Precision of results derived from MSAM procedure
Although experiments or analysis performed within the frame of 
MSAM procedure can be replicated in order to verify precision and 
reproducibility, this is not a mandatory prescription of the MSAM 
procedure (or even, of the conventional standard additions calibration 
method) since results are not derived from a single point measurement 
but by correlating at least four measured points.
This signifies that we can state the precision of measurements 
and results from the standard additions plot, without replicating 
experiments and analysis. 
For instance, one can calculate prevision bands, at a preset 
confidence level, around the standard additions regression line in order 
to anticipate what would be the outcome of a replicate experiment.
By way of example, in Figure 13 it is presented the standard 
additions plot of Norleucine of Figure 3 with calculated 95% confidence 
prevision bands.
It is obvious from Figure 13 that Norleucine will give very 
reproducible results. In fact, it is in the significance of the prevision 
bands that replicate measurements of experimental points will fall with 
95% probability within the prevision bands.
However, as the spread of points around the standard additions line 
increases, prevision bands diverge and differences between replicate 
experiments are expected to increase correspondingly.
Summary of results
The controlled and consistent preparation of biological amino 
acids silylated derivatives is made difficult by the presence of different 
functional groups in different amino acids. Conditions that are suitable 
for the silylation of a given group of amino acids may very well result in 
low and/or erratic yields of silylation reactions for some others. 
Of the amino acids that form proteins, those containing only the 
-COOH and alfa -NH2 groups (e.g., Ala, Val, Leu, Ile, Phe, Pro, etc.) are 
readily silylated and promptly appear in the Total Ion Chromatogram, 
under most silylation conditions, as sharp well developed peaks due to 
their 2TMS derivatives in which -Si(CH3)3 groups are substituted for 
the hydrogen on carboxylic group and one of the two -NH2 hydrogens:
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CH3
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bis(trimethylsilyl)-derivative 
of a simple amino acid 
(AminoAcid2TMS )
Glycine which, under most silylation conditions, is detected as a 
mixture of Gly2TMS and Gly3TMS surrogates and Phenylalanine 
which is detected as a mixture of Phe1TMS and Phe2TMS derivatives 
are emblematic exceptions to this rule:
O
NH2
OH
O
NH
O Si
Si
Gly Gly2TMS
Silylation
O
N
O
Si
Si
Si
Gly3TMS
Silylation
O
NH2
OH
O
NH2
O
Si
Phe Phe1TMS
Silylation
Phe2TMS
Silylation
O
NH
O
Si
Si
Simple amino acids (with the exception of Phenylalanine and 
Glycine) can be consistently silylated and quantified through their 
2TMS surrogates.
As we have demonstrated in this paper, Glycine can be treated as 
other simple amino acids provided that a short heat processing of the 
reaction mixture with a microwave oven (which is suitable to avoid the 
formation of Gly3TMS surrogate) is performed. 
On the contrary, possible inconsistencies in the quantification 
of Phenylalanine have been demonstrated but not solved and the 
formation of a mixture of Phe1TMS and Phe2TMS surrogates could 
not be avoided modifying silylation conditions.
The scenario complicates for amino acids that have functional 
groups in the side chain and which, in abstract, can give rise to a variety 
of silylated derivatives, starting with the 1TMS derivative up to 5TMS 
derivative.
Fortunately, many amino acids with functionalized side chains 
seem to strongly prefer the 3TMS derivative in which (beside the 
silylation of the -COOH and alfa -NH2 groups which takes place for all 
amino acids) an -Si(CH3)3 group is substitute for one of the hydrogen 
atoms of the functional group in the side chain. 
AminoAcid3TMS derivatives of functionalized amino acids have, 
in general, very suitable gas chromatographic properties. 
For instance, Serine and Threonine have an additional hydroxyl 
group in the side chain which is readily silylated so that they promptly 
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Figure 13: Standard addition plot of Norleucine (the same as in Figure 3) 
but with 95% confidence level prevision bands (broken lines) drawn around 
the standard additions regression line (solid line). Prevision bands have 
been calculated from the property “MeanPredictionsBands” of the function 
“LinearModelFit” of Wolfram Mathematica.  
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appear as Ser3TMS and Thr3TMS derivatives in the TIC as sharp well 
developed peaks:
O
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Si
Si
Si
Ser3TMS
O
NH
O O
Si
Si
Si
CH3
Thr3TMS
Apart from that, they behave in a manner very similar to simple 
amino acids.
From this we can infer that amino acids with functional groups in 
the side chain need to be converted to the 3TMS derivatives in order to 
develop the most suitable chromatographic properties.
But, obviously, there are exceptions to this general rule and this is 
the case of amino acids that have aromatic rings in their structure. So 
(in parallel to the fact noticed above that Phenylalanine1TMS is the only 
incompletely silylated amino acid which can be detected), Tyrosine2TMS 
and Tryptophan2TMS have very suitable chromatographic properties 
and give rise, when present in the injected reaction mixture, to sharp 
well-formed peaks in the TIC:
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Tyr2TMS Trp2TMS
However, the yield of the conversion reactions of Tyr and Trp 
to their 2TMS derivatives is very sensitive to the composition of the 
silylation mixture, to the temperature and length of the heat treatment 
and it appears problematic to be controlled. Inter alia, it has been 
demonstrated that silylation reactions of Tyrosine and Tryptophan 
to their Tyr2TMS and Trp2TMS surrogates progress faster as the 
concentration of the amino acid in the reaction medium increases and 
this very insidious phenomenon may create inconsistencies between 
points within the calibration curve or between the sample measured 
response and the calibration function. 
Under most silylation conditions, Arginine gives only a very weak 
and erratic GC/MS response through its artifact Ornithine4TMS [12]:
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Analogously, under most silylation conditions, Pyroglutamic Acid 
(PyrGlu) artifact is formed by a cyclization reaction involving the alfa 
amino group and, respectively, the -CONH2 and -COOH side groups of 
Glutamine and Glutamic Acid:
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Pyroglutamic acid is efficiently silylated with BSTFA and BSTFA/
TMCS mixtures, so much so that PyrGlu2TMS will be formed in high 
yields, compared to the regular silylation products, from Glutamine 
and Glutamic Acid. 
A cyclic amide silylation artifact, formed from a non-amino acid 
diamide, has previously been reported and its structure confirmed by 
proton NMR analysis [6]. 
The fact that Pyroglutamic Acid is formed both from Glutamine 
and Glutamic acid hinders its use for quantification of either amino 
acid. 
It has been demonstrated that a viable strategy is to direct the 
analytical procedure to the quantification of the sum of Glutamine and 
Glutamic Acid concentrations performing silylation under conditions 
in which the regular silylated derivative of Glutamic Acid (Glu3TMS) 
is not formed.
An artifact is also produced during silylation of Lysine. With pure 
BSTFA as the silylation agent, Lysine generally produces very low 
chromatographic responses through its Lysine3TMS and Lysine4TMS 
derivatives. When, in the attempt to enhance the yield of Lysine 
silylation reactions, BSTFA is enriched with TMCS, the methyl ester of 
Lysine2TMS appears with a high yield:
O
O
NH
NH
Si
SiBis(trimethylsilyl)-Lysine methyl ester 
(Lys2TMS methyl ester)
For maximum sensitivity, Lysine should then preferentially be 
silylated with a suitable BSTFA/TMCS mixture and the methyl ester of 
Lysine2TMS used as a surrogate for Lysine.
Unfortunately, the presence of TMCS in the reaction medium 
accelerates the decomposition of Cysteine whose silylated derivative, 
Cys3TMS, appears to be unstable both at low and high temperatures, 
so that it becomes very problematic to control the conversion 
Cys→Cys3TMS:
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NH2
SH OH
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S O
Si
Si
Si
Cysteine Cysteine3TMS
Silylation
It has been demonstrated that quantification of Cysteine can be 
made reducing the time scale of the MSAM experiment in order to 
avoid decomposition of the Cys3TMS surrogate. By consequence, for 
Cysteine, heat processing with a microwave oven is recommended.
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Conclusion
A single rigid protocol of analysis (based on a selected silylation 
reagent, solvent and prescribed heat processing) hardly will allow 
detection and quantification of all twenty biological amino acids in all 
possible samples via GC/MS analysis. 
However, a sample oriented approach, as the MSAM procedure 
presented in this paper, which, because incorporates in a single 
procedure calibration and analysis, allows changing silylation 
conditions case by case to target specific amino acids or groups of 
amino acids, could do the job. 
MSAM, which implements both the standard additions and 
internal standard calibration methods principles, is eminently suitable 
for compensating for matrix effects on the yield of silylation reactions 
which may create inconsistencies between the sample response and the 
calibration function.
MSAM procedure also incorporates a pilot compound which serves 
to check that the MSAM procedure has been properly performed and 
bugs (as, for instance, leakage of the reaction mixture from the reaction 
vials) have not occurred.
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